Caricamento...
T(H)2-cell targeted pulmonary siRNA delivery for the treatment of asthma
Despite the large number of drugs available for the treatment of asthma, in 5-10% of the patients this disease is not well controlled. While most treatments palliate symptoms, those suffering from severe and uncontrolled asthma could benefit more from a therapeutic approach addressing the root probl...
Salvato in:
| Pubblicato in: | Wiley Interdiscip Rev Nanomed Nanobiotechnol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7116616/ https://ncbi.nlm.nih.gov/pubmed/32267622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/wnan.1634 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|